CompletedNot Applicable

Osteofibrous Dysplasia (Kempson-Campanacci's Disease)

Italy50 participantsStarted 2019-08-08

Plain-language summary

The aim of the present study is to obtain long term follow-up in patients with osteofibrous dysplasia, to assess natural history of the disease, late results of treatment and in particular the potential and risk of progression to adamantinoma.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Male and female patients treated at Rizzoli Institute from 01 Jan 1943 to 31 Dic 2011 * Diagnosis of osteofibrous dysplasia pathologically confirmed * Written informed consent prior to any study-specific analysis and/or data collection Exclusion Criteria: * Patients with histological diagnosis different from osteofibrous dysplasia

What they're measuring

Osteofibrous Dysplasia (Kempson-Campanacci's disease): Long Term Follow-up Study on Natural History, Results of Treatment and Relationship with Adamantinoma

Timeframe: BASELINE

Trial details

NCT IDNCT04104763

SponsorIstituto Ortopedico Rizzoli

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2019-11-30

View on ClinicalTrials.gov More Osteofibrous Dysplasia trials